Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Antagon
2. Ganirelix
3. Ganirelix Acetate
4. Ganirelix Diacetate
5. Gnrh, N-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-et2-harg(6,8)-alanh2(10)-
6. Lhrh, N-acetyl-2-naphthylalanyl(1)-(4-chlorophenylalanyl)(2)-3-pyrdinylalanyl(3)-diethylhomoarginyl(6,8)-alaninamide(10)-
7. Lhrh,n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-et2-harg(6,8)-alanh2(10)-
8. N-ac-(2-naphthyl)ala-2-(4-cl-phe)-3-(3-pyridinyl-ala)-6,8-et2-harg-10-alanh2-lhrh
9. N-acetyl-3-(2-naphthyl)-d-alanyl-p-chloro-d-phenylalanyl-3-(3-pyridyl)-d-alanyl-l-seryl-l-tyrosyl-n(sup 6)-(n,n'-diethylamidino)-d-lysyl-l-leucyl-n(sup 6)-(n,n'-diethylamidino)-l-lysyl-l-prolyl-d-alaninamide Diacetate (salt)
10. Orgalutran
11. Rs 26306
12. Rs-26306
13. Rs-26306-298
1. Schembl719978
2. Gtpl3877
3. Ncgc00482546-01
4. Rs 26306
5. D 24598
6. D-24598
7. Q27077771
| Molecular Weight | 1570.3 g/mol |
|---|---|
| Molecular Formula | C80H113ClN18O13 |
| XLogP3 | 5.4 |
| Hydrogen Bond Donor Count | 16 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 48 |
| Exact Mass | 1568.8423034 g/mol |
| Monoisotopic Mass | 1568.8423034 g/mol |
| Topological Polar Surface Area | 452 Ų |
| Heavy Atom Count | 112 |
| Formal Charge | 0 |
| Complexity | 3030 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Ganirelix acetate |
| Drug Label | Ganirelix Acetate Injection is a synthetic decapeptide with high antagonistic activity against naturally occurring gonadotropin-releasing hormone (GnRH). Ganirelix Acetate is derived from native GnRH with substitutions of amino acids at positions 1,... |
| Active Ingredient | Ganirelix acetate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 250mcg base/0.5ml |
| Market Status | Prescription |
| Company | Organon Usa |
| 2 of 2 | |
|---|---|
| Drug Name | Ganirelix acetate |
| Drug Label | Ganirelix Acetate Injection is a synthetic decapeptide with high antagonistic activity against naturally occurring gonadotropin-releasing hormone (GnRH). Ganirelix Acetate is derived from native GnRH with substitutions of amino acids at positions 1,... |
| Active Ingredient | Ganirelix acetate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 250mcg base/0.5ml |
| Market Status | Prescription |
| Company | Organon Usa |
Hormone Antagonists
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)
Global Sales Information
ABOUT THIS PAGE
A Orgalutran manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Orgalutran, including repackagers and relabelers. The FDA regulates Orgalutran manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Orgalutran API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Orgalutran supplier is an individual or a company that provides Orgalutran active pharmaceutical ingredient (API) or Orgalutran finished formulations upon request. The Orgalutran suppliers may include Orgalutran API manufacturers, exporters, distributors and traders.
Orgalutran Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Orgalutran GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Orgalutran GMP manufacturer or Orgalutran GMP API supplier for your needs.
A Orgalutran CoA (Certificate of Analysis) is a formal document that attests to Orgalutran's compliance with Orgalutran specifications and serves as a tool for batch-level quality control.
Orgalutran CoA mostly includes findings from lab analyses of a specific batch. For each Orgalutran CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Orgalutran may be tested according to a variety of international standards, such as European Pharmacopoeia (Orgalutran EP), Orgalutran JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Orgalutran USP).
LOOKING FOR A SUPPLIER?
